Your browser doesn't support javascript.
loading
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.
Santoro, Valeria; Jia, Ruochen; Thompson, Hannah; Nijhuis, Anke; Jeffery, Rosemary; Kiakos, Konstantinos; Silver, Andrew R; Hartley, John A; Hochhauser, Daniel.
Afiliação
  • Santoro V; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Jia R; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Thompson H; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Nijhuis A; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Jeffery R; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Kiakos K; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Silver AR; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Hartley JA; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS);
  • Hochhauser D; Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London, London, UK (VS, RJ, KK, JAH, DH); Colorectal Cancer Genetics Group, Blizard Institute, London, UK (HT, AN, RJ, ARS); d.hochhauser@ucl.ac.uk.
J Natl Cancer Inst ; 108(6): djv394, 2016 Jun.
Article em En | MEDLINE | ID: mdl-26719345
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Espécies Reativas de Oxigênio / Receptores ErbB / Cetuximab Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Espécies Reativas de Oxigênio / Receptores ErbB / Cetuximab Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos